Tos-Gly-Pro-Arg-ANBA-IPA

CAS No. 99700-50-2

Tos-Gly-Pro-Arg-ANBA-IPA( tos-GPR-ANBA-IPA )

Catalog No. M29725 CAS No. 99700-50-2

Tos-Gly-Pro-Arg-ANBA-IPA is a chromogenic peptide substrate. Tos-Gly-Pro-Arg-ANBA-IPA is used for the rapid and specific photometric assay of recombinant hirudin (r-hirudin).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 311 Get Quote
10MG 446 Get Quote
50MG 1337 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Tos-Gly-Pro-Arg-ANBA-IPA
  • Note
    Research use only, not for human use.
  • Brief Description
    Tos-Gly-Pro-Arg-ANBA-IPA is a chromogenic peptide substrate. Tos-Gly-Pro-Arg-ANBA-IPA is used for the rapid and specific photometric assay of recombinant hirudin (r-hirudin).
  • Description
    Tos-Gly-Pro-Arg-ANBA-IPA is a chromogenic peptide substrate. Tos-Gly-Pro-Arg-ANBA-IPA is used for the rapid and specific photometric assay of recombinant hirudin (r-hirudin).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    tos-GPR-ANBA-IPA
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    99700-50-2
  • Formula Weight
    687.77
  • Molecular Formula
    C30H41N9O8S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Ethylmalonic acid

    Ethylmalonic acid can be found in blood cerebrospinal fluid (CSF) and urine as well as in human fibroblasts prostate and skeletal muscle tissues. Moreover ethylmalonic acid is found to be associated with anorexia nervosa and malonyl-CoA decarboxylase deficiency. Ethylmalonic acid is a non-carcinogenic potentially toxic compound.

  • Valbenazine

    A novel, highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor; is approved for the treatment of tardive dyskinesia.

  • Presatovir

    Presatovir (GS-5806) is a novel, orally bioavailable RSV fusion inhibitor (mean EC50: 0.43 nM).Presatovir exhibits potent activity against a wide range of RSV A and B clinical isolates (mean EC50: 0.43 nM) [1]. GS-5806 inhibits pre to post triggered conformational changes of RSV F protein, suggesting a possible mechanism for antiviral activity.